Platelet mitochondrial dysfunction in critically ill patients: Comparison between sepsis and cardiogenic shock

Critical Care

Volumn 19, Issue 1, 2015, Pages

  Protti, Alessandro ^a   Fortunato, Francesco ^a   Artoni, Andrea ^a   Lecchi, Anna ^a   Motta, Giovanna ^a   Mistraletti, Giovanni ^a   Novembrino, Cristina ^a   Comi, Pietro ^a   Gattinoni, Luciano ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ADENOSINE DIPHOSPHATE; CITRATE SYNTHASE; COLLAGEN; MITOCHONDRIAL ENZYME; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); THROMBIN RECEPTOR ACTIVATING PEPTIDE; MULTIENZYME COMPLEX;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CARDIOGENIC SHOCK; CASE CONTROL STUDY; CELL DENSITY; CELLULAR SECRETION; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DISEASE SEVERITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVITY; FEMALE; HUMAN; INTENSIVE CARE; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY CHAIN; SEPSIS; SEPTIC SHOCK; SPECTROPHOTOMETRY; THROMBOCYTE; THROMBOCYTE AGGREGATION; COMPARATIVE STUDY; CRITICAL ILLNESS; CYTOLOGY; ELECTRON TRANSPORT; ENZYMOLOGY; METABOLISM; MITOCHONDRION; PHYSIOLOGY;

BLOOD PLATELETS; CRITICAL ILLNESS; ELECTRON TRANSPORT; ELECTRON TRANSPORT CHAIN COMPLEX PROTEINS; HUMANS; MITOCHONDRIA; PLATELET AGGREGATION; PROSPECTIVE STUDIES; SEPSIS; SHOCK, CARDIOGENIC;

EID: 84924272613     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/s13054-015-0762-7     Document Type: Article

References (45)

1. Siekevitz P. Powerhouse of the cell. Sci Am. 1957;197:131-40.
2. Singer M, De Santis V, Vitale D, Jeffcoate W. Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation. Lancet. 2004;364:545-8.
3. Protti A, Singer M. Strategies to modulate cellular energetic metabolism during sepsis. Novartis Found Symp. 2007;280:7-16.
4. Nicholls DG, Ferguson SJ. Bioenergetics. London: Academic; 2002.
5. Protti A, Fortunato F, Monti M, Vecchio S, Gatti S, Comi GP, et al. Metformin overdose, but not lactic acidosis per se, inhibits oxygen consumption in pigs. Crit Care. 2012;16:R75.
6. Protti A, Lecchi A, Fortunato F, Artoni A, Greppi N, Vecchio S, et al. Metformin overdose causes platelet mitochondrial dysfunction in humans. Crit Care. 2012;16:R180.
7. Protti A, Fortunato F, Caspani ML, Pluderi M, Lucchini V, Grimoldi N, et al. Mitochondrial changes in platelets are not related to those in skeletal muscle during human septic shock. PLoS One. 2014;9:e96205.
8. Lorente L, Martín MM, López-Gallardo E, Iceta R, Blanquer J, Solé-Violán J, et al. Higher platelet cytochrome oxidase specific activity in surviving than in non-surviving septic patients. Crit Care. 2014;18:R136.
9. Guppy M, Abas L, Neylon C, Whisson ME, Whitham S, Pethick DW, et al. Fuel choices by human platelets in human plasma. Eur J Biochem. 1997;244:161-7.
10. Daniel JL, Molish IR, Holmsen H. Radioactive labeling of the adenine nucleotide pool of cells as a method to distinguish among intracellular compartments. Studies on human platelets. Biochim Biophys Acta. 1980;632:444-53.
11. 2+ secretion. Blood. 1981;57:956-66.
12. Verhoeven AJ, Mommersteeg ME, Akkerman JW. Quantification of energy consumption in platelets during thrombin-induced aggregation and secretion. Tight coupling between platelet responses and the increment in energy consumption. Biochem J. 1984;221:777-87.
13. Mills DC. Changes in the adenylate energy charge in human blood platelets induced by adenosine diphosphate. Nat New Biol. 1973;243:220-2.
14. Holmsen H, Setkowsky CA, Day HJ. Effects of antimycin and 2-deoxyglucose on adenine nucleotides in human platelets. Role of metabolic adenosine triphosphate in primary aggregation, secondary aggregation and shape change of platelets. Biochem J. 1974;144:385-96.
15. Holmsen H, Robkin L, Day HJ. Effects of antimycin A and 2-deoxyglucose on secretion in human platelets. Differential inhibition of the secretion of acid hydrolases and adenite nucleotides. Biochem J. 1979;182:413-9.
16. Tomasiak M, Stelmach H, Rusak T, Wysocka J. Nitric oxide and platelet energy metabolism. Acta Biochim Pol. 2004;51:789-803.
17. Rusak T, Tomasiak M, Ciborowski M. Peroxynitrite can affect platelet responses by inhibiting energy production. Acta Biochim Pol. 2006;53:769-76.
18. Barile CJ, Herrmann PC, Tyvoll DA, Collman JP, Decreau RA, Bull BS. Inhibiting platelet-stimulated blood coagulation by inhibition of mitochondrial respiration. Proc Natl Acad Sci U S A. 2012;109:2539-43.
19. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101:1644-55.
20. Hasdai D, Topol EJ, Califf RM, Berger PB, Holmes Jr DR. Cardiogenic shock complicating acute coronary syndromes. Lancet. 2000;356:749-56.
21. Cattaneo M. Light transmission aggregometry and ATP release for the diagnostic assessment of platelet function. Semin Thromb Hemost. 2009;35:158-67.
22. Cattaneo M, Lecchi A, Lombardi R, Gachet C, Zighetti ML. Platelets from a patient heterozygous for the defect of P2CYC receptors for ADP have a secretion defect despite normal thromboxane A2 production and normal granule stores: further evidence that some cases of platelet 'primary secretion defect' are heterozygous for a defect of P2CYC receptors. Arterioscler Thromb Vasc Biol. 2000;20:E101-6.
23. Boulos M, Astiz ME, Barua RS, Osman M. Impaired mitochondrial function induced by serum from septic shock patients is attenuated by inhibition of nitric oxide synthase and poly(ADP-ribose) synthase. Crit Care Med. 2003;31:353-8.
24. Belikova I, Lukaszewicz AC, Faivre V, Damoisel C, Singer M, Payen D. Oxygen consumption of human peripheral blood mononuclear cells in severe human sepsis. Crit Care Med. 2007;35:2702-8.
25. Garrabou G, Morén C, López S, Tobías E, Cardellach F, Miró O, et al. The effects of sepsis on mitochondria. J Infect Dis. 2012;205:392-400.
26. Sjövall F, Morota S, Asander Frostner E, Hansson MJ, Elmér E. Cytokine and nitric oxide levels in patients with sepsis - temporal evolvement and relation to platelet mitochondrial respiratory function. PLoS One. 2014;9:e97673.
27. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature. 2010;464:104-7.
28. Xiao W, Mindrinos MN, Seok J, Cuschieri J, Cuenca AG, Gao H, et al. A genomic storm in critically injured humans. J Exp Med. 2011;208:2581-90.
29. Adrie C, Adib-Conquy M, Laurent I, Monchi M, Vinsonneau C, Fitting C, et al. Successful cardiopulmonary resuscitation after cardiac arrest as a 'sepsis-like' syndrome. Circulation. 2002;106:562-8.
30. Wallace KB, Starkov AA. Mitochondrial targets of drug toxicity. Annu Rev Pharmacol Toxicol. 2000;40:353-88.
31. Barnhill AE, Brewer MT, Carlson SA. Adverse effects of antimicrobials via predictable or idiosyncratic inhibition of host mitochondrial components. Antimicrob Agents Chemother. 2012;56:4046-51.
32. Huet O, Dupic L, Batteux F, Matar C, Conti M, Chereau C, et al. Post-resuscitation syndrome: potential role of hydroxyl radical-induced endothelial cell damage. Crit Care Med. 2011;39:1712-20.
33. Penniall R. The effects of salicylic acid on the respiratory activity of mitochondria. Biochim Biophys Acta. 1958;30:247-51.
34. Cowan DH, Bowman LS, Fratianne RB, Ahmed F. Platelet aggregation as a sign of septicemia in thermal injury. A prospective study. JAMA. 1976;235:1230-4.
35. Lundahl TH, Petersson J, Fagerberg IH, Berg S, Lindahl TL. Impaired platelet function correlates with multi-organ dysfunction. A study of patients with sepsis. Platelets. 1998;9:223-5.
36. Yaguchi A, Lobo FL, Vincent JL, Pradier O. Platelet function in sepsis. J Thromb Haemost. 2004;2:2096-102.
37. Adamzik M, Görlinger K, Peters J, Hartmann M. Whole blood impedance aggregometry as a biomarker for the diagnosis and prognosis of severe sepsis. Crit Care. 2012;16:R204.
38. Pareti FI, Capitanio A, Mannucci L, Ponticelli C, Mannucci PM. Acquired dysfunction due to the circulation of 'exhausted' platelets. Am J Med. 1980;69:235-40.
39. Pareti FI, Capitanio A, Mannucci PM. Acquired storage pool disease in platelets during disseminated intravascular coagulation. Blood. 1976;48:511-5.
40. Weiss HJ. Platelet physiology and abnormalities of platelet function (second of two parts). N Engl J Med. 1975;293:580-8.
41. Pareti FI, Day HJ, Mills DC. Nucleotide and serotonin metabolism in platelets with defective secondary aggregation. Blood. 1974;44:789-800.
42. Verhoeven AJ, Mommersteeg ME, Akkerman JW. Comparative studies on the energetics of platelet responses induced by different agonists. Biochem J. 1986;236:879-87.
43. Stibbe J, Holmsen H. Effects of sodium azide on platelet function. Thromb Haemost. 1977;38:1042-53.
44. Chandel NS, Budinger GRS, Choe SH, Schumacker PT. Cellular respiration during hypoxia. Role of cytochrome oxidase as the oxygen sensor in hepatocytes. J Biol Chem. 1997;272:18808-16.
45. Boudreau LH, Duchez AC, Cloutier N, Soulet D, Martin N, Bollinger J, et al. Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflammation. Blood. 2014;124:2173-83.